Pharmaceutical Analytical Testing Outsourcing Market Outlook Report 2024-2032

IMARC Group, a leading market research company, has recently releases report titled “Pharmaceutical Analytical Testing Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032” The global pharmaceutical analytical testing outsourcing market size reached US$ 8.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.76% during 2024-2032.

Request For Sample Copy of Report For More Detailed Market insight: https://www.imarcgroup.com/pharmaceutical-analytical-testing-outsourcing-market/requestsample

Factors Affecting the Growth of the Pharmaceutical Analytical Testing Outsourcing Industry:  

 

• Increasing Regulatory Requirements:

Outsourced analytical testing service providers possess specialized knowledge and experience in regulatory compliance. This expertise is invaluable for pharmaceutical companies aiming to ensure that their products meet all necessary standards without the burden of constantly monitoring regulatory updates themselves. Moreover, regulatory agencies demand high standards of quality and safety for pharmaceutical products. Outsourced testing laboratories offer sophisticated testing services, including purity, potency, stability, and contaminant testing, all of which are essential for meeting these stringent requirements. By leveraging the capabilities of outsourcing partners, pharmaceutical companies can more effectively ensure the safety and efficacy of their products.

 

• Technological Advancements:

Modern analytical technologies, such as high-performance liquid chromatography (HPLC), gas chromatography (GC), mass spectrometry (MS), and next-generation sequencing (NGS), offer enhanced capabilities for the detection, quantification, and analysis of pharmaceutical compounds. Outsourcing partners that invest in these cutting-edge technologies can provide more accurate, sensitive, and comprehensive testing services, making them attractive to pharmaceutical companies seeking the highest quality standards. Furthermore, advancements in technology contribute to faster analytical processes, allowing for quicker turnaround times on testing results. This efficiency is crucial for pharmaceutical companies looking to accelerate their drug development timelines and achieve faster time-to-market for their products.

 

• Expansion of Biopharmaceutical Sector:

Biopharmaceutical products derived from living organisms are inherently more complex than traditional small-molecule drugs. Their complexity requires advanced analytical techniques for characterization, safety, and efficacy testing. Outsourcing these specialized testing services allows pharmaceutical companies to access the necessary expertise and technology without substantial internal investment. In addition, biopharmaceuticals demand a range of specialized testing services, such as immunogenicity testing, protein characterization, and cell bank characterization. These specialized services require advanced technologies and expertise that many pharmaceutical companies may not have. Outsourcing provides access to a wide array of specialized testing capabilities tailored as per the unique needs of biopharmaceuticals.

Leading Companies Operating in the Global Pharmaceutical Analytical Testing Outsourcing Industry:

 

• Ajinomoto Bio-Pharma Services (Ajinomoto Co. Inc.)

 

• Alcami Corporation Inc.

 

• Boston Analytical Inc.

 

• Catalent Inc.

 

• Charles River Laboratories International Inc.

 

• Eurofins Scientific SE

 

• Intertek Group plc

 

• Laboratory Corporation of America Holdings

 

• Pace Analytical Services LLC

 

• SGS S.A.

 

• Thermo Fisher Scientific Inc.

 

• West Pharmaceutical Services Inc.

 

• WuXi AppTec Inc

Pharmaceutical Analytical Testing Outsourcing Market Report Segmentation: 

By Type:

 

• Active Pharmaceutical Ingredients (API)

 

• Additives

 

• Finished Products

On the basis of the type, the market has been classified into active pharmaceutical ingredients (API), additives, and finished products.

By Service:

 

• Bioanalytical Testing

   

  • Clinical

   

  • Non-Clinical

 

• Method Development and Validation

   

  • Extractable and Leachable

   

  • Impurity Method

   

  • Technical Consulting

   

  • Others

 

• Stability Testing

   

  • Drug Substance

   

  • Stability Indicating Method Validation

   

  • Accelerated Stability Testing

   

  • Photostability Testing

   

  • Others

 

• Others

Based on the services, the market has been divided into bioanalytical testing (clinical and non-clinical), method development and validation (extractable and leachable, impurity method, technical consulting, and others), stability testing (drug substance, stability indicating method validation, accelerated stability testing, photostability testing, and others), and others.

By End User:

 

• Pharmaceutical Companies

 

• Biopharmaceutical Companies

 

• Contract Research Organizations

Pharmaceutical companies hold the biggest market share as the complexity and regulatory requirements of pharmaceutical product development necessitate a wide range of testing services, ranging from drug discovery to post-market surveillance.

Regional Insights:

 

• North America (United States, Canada)

 

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

 

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

 

• Latin America (Brazil, Mexico, Others)

 

• Middle East and Africa

North America enjoys the leading position in the pharmaceutical analytical testing outsourcing market on account of a stringent regulatory framework, including the Food and Drug Administration (FDA), which necessitates comprehensive analytical testing to comply with regulatory standards.

Global Pharmaceutical Analytical Testing Outsourcing Market Trends:

Advanced software and data analytics tools are becoming essential in pharmaceutical analytical testing. These tools enable the efficient management and analysis of large datasets, providing deeper insights into the data collected during testing. Outsourcing partners equipped with these technological solutions can offer added value to pharmaceutical companies through sophisticated data analysis and interpretation, which is propelling the growth of the market.

Additionally, the rising adoption of personalized medicine and advanced therapy medicinal products (ATMPs), including gene and cell therapies, is driving the demand for specialized analytical testing services. These products require highly specialized analytical approaches for characterization, safety, and efficacy testing, leading to increased outsourcing as companies seek partners with the necessary expertise and capabilities.

Other Key Points Covered in the Report:

 

• Porters Five Forces Analysis

 

• Value Chain Analysis

 

• Strategic Recommendations

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163